Serum hepatitis (SH) virus was isolated in tissue culture from the blood of each of the five human volunteers 41 to 90 days following their inoculation with NIH icterogenic plasma pool VI. Six other strains of hepatitis viruses were isolated from patient sources; one from a case of clinical serum hepatitis and the remainder from five (5) cases of clinically diagnosed infectious hepatitis. All agents were grown in human lung cell and rabbit kidney tissue culture systems. SH 204 virus was neutralized by specific rabbit antisera prepared against viruses SH 211, SH 204, SH 210, SH‐Neib, IH‐MJ and IH‐Horst. These antisera at a final dilution of 1:40 neutralized 10 to 1,000 TCID50 units of the SH 204 virus. Cross complement fixation tests were carried out with the ten hepatitis viruses against specific rabbit antisera which was prepared against each of the virus agents. Irrespective of the source of isolation of the SH or IH virus, there were no apparent differences in the antigenic structure of the viruses, since all produced a common complement fixing antibody in rabbits immunized with the different viral agents. The complement fixation titers observed ranged from 1:200 to 1:3000. In sharp contrast, normal human serum and normal rabbit kidney and human lung cell tissue culture fluids, when tested against antisera produced to these agents as antigens, fixed complement in a range of titer of only 1:8 to 1:96.Complement fixation tests were carried out against specific antisera for many of the other human enteric viruses. SH virus did not fix complement with specific antisera prepared against Coxsackie, Group B1 virus types one to six; Coxsackie, Group A, Virus, type nine; Echo, types one, three, six, eight, 23, 26, 28; Folio viruses, types one, two and three; and Para‐influenza, type three virus. However, the SH virus was found to fix complement with antisera prepared against Echo virus, types two, seven, 24 and 25, but the titers observed ranged only from 1:64 to 1:128. Complement fixing antibodies were also demonstrated in three of 25 normal calf sera tested, but were not demonstrated in normal serum obtained from guinea pigs, rabbits, rhesus monkey, horse, human infant, sheep or cat. Antisera against infectious canine hepatitis virus did not fix complement with the SH virus. Finally, convalescent sera obtained from the volunteers who had been inoculated with the icterogenic plasma pool, demonstrated a high titer of complement fixing antibodies against the SH virus.